PATENT CLAIM ANALYSIS

Application Number: 15750425
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "139100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 91):
A method for expanding a population of T cells and/or NK cells, wherein T cells and/or NK cells are contacted in vitro, in vivo or ex vivo with an antibody or antigen binding fragment which is capable of binding to CD122 and common \u03b3 chain (\u03b3c), and wherein the antibody or antigen binding fragment is an IL-2 receptor agonist.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15229336', '15495048', '15486468', '15521685', '15521434']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7709616580946792
- 35 USC 102 Novelty (BERT): 0.7010022658102534
- Combined Prediction Score: 0.7639657188662367
- Mean Citation Score: 532.3024059999998
- Max Citation Score: 948.52997
- Similarity Product: 697.4345859993541

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test